Greenwich LifeSciences, Inc. (GLSI) Deep Dive Video
Summary
Greenwich LifeSciences is a high-risk, high-upside clinical biotech where one Phase III breast cancer vaccine candidate could either unlock multibillion-dollar value or collapse the equity thesis.